Hollencrest Capital Management Vaxxinity, Inc. Transaction History

Hollencrest Capital Management

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 06, 2023	BUY	$1.31 - $2.62 $26,200 - $52,400	20,000 New	20,000 $28,000
Q2 2022 Jul 21, 2022	BUY	$1.55 - $6.95 $31,000 - $139,000	20,000 New	20,000 $31,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hollencrest Capital Management with notifications on news.